Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CETP | P11597 | 20/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4223079 | 0.88 | CETP (0.38) | CETP | |
| SCHEMBL3979337 | 0.87 | CETP (0.39) | CETP | |
| SCHEMBL3910899 | 0.85 | CETP (0.38) | CETP | |
| SCHEMBL27743969 | 0.84 | CETP (0.41) | CETP | |
| SCHEMBL3910894 | 0.80 | CETP (0.38) | CETP | |
| SCHEMBL1600913 | 0.76 | CETP (0.47) | CETP | |
| SCHEMBL1600443 | 0.76 | CETP (0.46) | CETP | |
| SCHEMBL1600442 | 0.76 | CETP (0.46) | CETP | |
| SCHEMBL4220329 | 0.76 | CETP (0.39) | CETP | |
| SCHEMBL3578647 | 0.75 | CETP (0.37) | CETP |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2018376-A1 | BENZYLAMINE DERIVATIVES AS CETP INHIBITORS | Novartis Pharma AG (CH) | 2009-01-28 | — | — | EP | disclosed |
| WO-2007132906-A1 | BENZYLAMINE DERIVATIVES AS CETP INHIBITORS | NOVARTIS AG (CH) | 2007-11-22 | — | — | WO | disclosed |